Episodes (Page 4)
✨
Discusses antibiotic development, immunotherapy targeting, and sustainable pharma labs.
✨
Highlights advances in immunotherapy, including NK and CAR-T cell combinations.
✨
Discusses mRNA vaccine contract cancellations and other clinical trial news.
✨
Features Steve Ruston discussing Persica Pharmaceuticals' non-opioid chronic pain treatment.
✨
Highlights neuroscience drug discovery updates from the Alzheimer's Association conference.
✨
Focuses on manufacturing concerns following FDA rejection of a gene therapy.
✨
Features Thijs Spoor discussing Perspective Therapeutics' radiopharmaceutical cancer treatments.
✨
Highlights innovation and hurdles in gene therapy development.
✨
Explores AI applications in clinical trials and antibody discovery.
✨
Focuses on drug discovery news and regulatory approvals in the EU.
✨
Discusses FDA removal of red tape for CAR-T therapy access.
✨
Highlights UK drug discovery expertise and research locations.
✨
Emphasizes advanced technologies in drug discovery success.
✨
Features Professor Jonathan Kagan on mRNA and new vaccine development.
✨
Covers significant developments in oncology drug discovery.
✨
Highlights the vital role of genetics in drug discovery.
✨
Explores advances and challenges in neuroscience drug discovery.
✨
Shines a light on the importance of in-person conferences.
✨
Features Dr. Emil Lou discussing gastrointestinal cancer research.
✨
Highlights a major deal between Eli Lilly and Rznomics for RNA therapies.